- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 899.49M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 894.37M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 891.76M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 891.76M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$43.07M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$77.59M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $575.45M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $339.73M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $115.76M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.02B |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $697.54M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $614.29M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $696.79M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $473.78M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $148.12M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $50.34M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $587.37M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $91.33M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $10.92M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $153.12M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.16B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.11B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.10 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.19 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.10 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.19 |
| Net Income | Q3 2025 · Sep 30, 2025 | $3.48M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$93.72M |
| Net Income | Q3 2025 · Jun 30, 2025 | $3.43M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$100.62M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$576K |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $168.77M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$61.06M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | $230.41M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $7.2M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$123.36M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$10.19M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $176.02M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $28.28M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $55.27M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $11.13M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $39.57M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $3.58M |